Memory Pharmaceuticals

company

About

Memory Pharmaceuticals is focused on developing drug candidates for the treatment of central nervous system conditions.

  • 101 - 250

Details

Last Funding Type
Post-IPO Debt
Last Funding Money Raised
$10M
Industries
Biotechnology,Neuroscience,Pharmaceutical
Founded date
Jan 1, 1997
Number Of Employee
101 - 250
Operating Status
Active

Memory Pharmaceuticals Corp., a biopharmaceutical company, focuses on the discovery and development of drug candidates for the treatment of central nervous system conditions. It offers drugs for neurological diseases associated with aging, such as Alzheimer's disease, as well as psychiatric disorders, such as schizophrenia, cognitive impairment associated with schizophrenia (CIAS), and depression.

The company was incorporated in 1997 and is based in Montvale, New Jersey. As of December 31, 2008, Memory Pharmaceuticals Corp. operates as a subsidiary of Hoffmann-La Roche Inc.

Funding Rounds

Number of Funding Rounds
Total Funding Amount
1
$10M
Memory Pharmaceuticals has raised a total of $10M in funding over 2 rounds. Their latest funding was raised on Mar 16, 2007 from a Post-IPO Debt round.
Announced Date Round Money Raised Number of Investors Lead Investors Post Valuation
Mar 16, 2007 Post-IPO Debt $10M 1 Hercules Capital Detail

Investors

Number of Lead Investors
Number of Investors
1
1
Memory Pharmaceuticals is funded by 1 investors. Hercules Capital are the most recent investors.
Investor Name Lead Investor Funding Round
Hercules Capital Yes Post-IPO Debt